Endovascular thrombectomy in selected patients with active cancer and thrombocytopenia: outcomes under an institutional platelet transfusion practice - Takeaways - MDSpire

Endovascular thrombectomy in selected patients with active cancer and thrombocytopenia: outcomes under an institutional platelet transfusion practice

  • By

  • Hyung Jun Kim

  • Tae-Jin Song

  • Jin-Soo Lee

  • Keon-Ha Kim

  • Woo-Keun Seo

  • Pyoung Jeon

  • Gyeong-Moon Kim

  • Jong-Won Chung

  • Oh Young Bang

  • June 23, 2026

  • 0 min

Share

  • 1

    This study analyzed the safety and outcomes of endovascular thrombectomy (EVT) in patients with active cancer and thrombocytopenia.

  • 2

    Among 98 patients, 40 pairs were matched for analysis, revealing no significant differences in hemorrhagic complications between groups.

  • 3

    Patients with thrombocytopenia had worse functional outcomes at 90 days, with a median modified Rankin Scale of 6 compared to 3 in the non-thrombocytopenia group.

  • 4

    The study found no significant association between thrombocytopenia and increased hemorrhagic complications during EVT.

  • 5

    Findings suggest that thrombocytopenia may not preclude EVT in active cancer patients, but results should be interpreted cautiously due to study limitations.

Original Source(s)

Endovascular thrombectomy in selected patients with active cancer and thrombocytopenia: outcomes under an institutional platelet transfusion practice

  • by Hyung Jun Kim, Tae-Jin Song, Jin-Soo Lee, Keon-Ha Kim, Woo-Keun Seo, Pyoung Jeon, Gyeong-Moon Kim, Jong-Won Chung, Oh Young Bang

  • June 23, 2026

Related Content

Spontaneous intracerebral hemorrhage associated with lenvatinib in advanced hepatocellular carcinoma without conventional risk factors: a case report literature review

Multimodal neuroimaging protocol to explore the neural mechanisms of Tiao Shen Li Yan acupuncture in post-stroke dysphagia: a randomized sham-controlled clinical trial

Real-world use and impact of direct oral anticoagulants among atrial fibrillation patients with cardioembolic stroke